Kobayashi Pharma Extends Drop on Report a User of Its Pills Died

Kobayashi Pharma Extends Drop on Report a User of Its Pills DiedConsumer Lender Curo Goes Bankrupt as Debt Pile Takes TollBitcoin Volatility Becomes More Intense in US Compared With AsiaTime to shift that parked RRSP contribution into drive'Like throwing money down the drain': Food waste is out as grocery prices rise and budgets tightenDale Jackson: 4 tax tools that can keep more of your money investedTax return software makes filing easy, but knowing when to hire a professional is...

29?Adam Neumann Offers to Buy Back WeWork for More Than $500 Million, WSJ ReportsLondon Homes Still Cost 12 Times Earnings Despite Fall in PricesChina’s Tech Sector May Rival Property as Growth Driver, BE SaysEngland’s Homes Found More Cramped Than Those In New York CityReal Estate Investors Sitting on ‘Huge’ CO2 Risk Turn to LawyersBurned Before, Bond Markets Resume Rate-Cutting Trades WorldwideHong Kong’s Big Estates Post 32% Slump in Weekend TransactionsCountry Garden, Vanke to Expose Extent...

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca to buy Amolyt Pharma for US$1.05-billion to boost rare-disease portfolioThe deal, which includes an $800-million upfront payment and an additional contingent payment of $250-million on achieving a specified regulatory milestone, is expected to close by the third quarter of 2024
Source: globeandmail - 🏆 5. / 92 Read more »

Novo Nordisk Agrees to Buy Cardior Pharma for Up to €1 BillionNovo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to €1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease.
Source: BNNBloomberg - 🏆 83. / 50 Read more »